177.39
Schlusskurs vom Vortag:
$179.36
Offen:
$178.99
24-Stunden-Volumen:
1.58M
Relative Volume:
1.18
Marktkapitalisierung:
$31.62B
Einnahmen:
$15.41B
Nettoeinkommen (Verlust:
$1.37B
KGV:
23.65
EPS:
7.5
Netto-Cashflow:
$2.11B
1W Leistung:
-4.57%
1M Leistung:
-4.88%
6M Leistung:
-24.45%
1J Leistung:
-29.85%
Iqvia Holdings Inc Stock (IQV) Company Profile
Firmenname
Iqvia Holdings Inc
Sektor
Branche
Telefon
919-998-2000
Adresse
2400 ELLIS ROAD, DURHAM, NC
Vergleichen Sie IQV mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
IQV
Iqvia Holdings Inc
|
177.39 | 31.62B | 15.41B | 1.37B | 2.11B | 7.50 |
![]()
TMO
Thermo Fisher Scientific Inc
|
500.16 | 196.14B | 42.88B | 6.34B | 7.27B | 16.53 |
![]()
DHR
Danaher Corp
|
205.85 | 150.17B | 23.88B | 3.90B | 5.30B | 5.28 |
![]()
IDXX
Idexx Laboratories Inc
|
415.87 | 34.36B | 3.90B | 887.87M | 798.08M | 10.67 |
![]()
A
Agilent Technologies Inc
|
116.69 | 33.28B | 6.53B | 1.26B | 1.31B | 4.35 |
Iqvia Holdings Inc Stock (IQV) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-02-03 | Herabstufung | BTIG Research | Buy → Neutral |
2024-12-20 | Eingeleitet | Stephens | Overweight |
2024-10-14 | Eingeleitet | Redburn Atlantic | Buy |
2024-09-04 | Eingeleitet | RBC Capital Mkts | Outperform |
2024-07-24 | Herabstufung | Jefferies | Buy → Hold |
2024-06-06 | Eingeleitet | Goldman | Buy |
2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
2024-02-15 | Herabstufung | Guggenheim | Buy → Neutral |
2024-02-13 | Eingeleitet | BTIG Research | Buy |
2023-11-02 | Herabstufung | Robert W. Baird | Outperform → Neutral |
2023-09-06 | Eingeleitet | HSBC Securities | Buy |
2023-03-17 | Eingeleitet | Truist | Buy |
2022-12-06 | Eingeleitet | Cowen | Outperform |
2022-11-17 | Herabstufung | Citigroup | Buy → Neutral |
2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
2022-07-15 | Eingeleitet | SVB Leerink | Outperform |
2022-05-24 | Eingeleitet | Guggenheim | Buy |
2022-04-29 | Hochstufung | Piper Sandler | Neutral → Overweight |
2022-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
2021-04-16 | Hochstufung | Stephens | Equal-Weight → Overweight |
2021-03-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
2021-03-03 | Eingeleitet | Barclays | Overweight |
2020-07-07 | Eingeleitet | Stephens | Equal-Weight |
2020-03-02 | Eingeleitet | Deutsche Bank | Buy |
2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
2020-01-07 | Eingeleitet | Citigroup | Buy |
2019-12-13 | Hochstufung | CFRA | Sell → Hold |
2019-11-14 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
2019-06-21 | Hochstufung | Mizuho | Neutral → Buy |
2019-05-28 | Eingeleitet | SVB Leerink | Outperform |
2019-01-18 | Hochstufung | Jefferies | Hold → Buy |
2018-10-09 | Eingeleitet | UBS | Buy |
2018-10-02 | Bestätigt | Robert W. Baird | Outperform |
2018-07-25 | Hochstufung | BofA/Merrill | Neutral → Buy |
2018-07-25 | Bestätigt | Stifel | Buy |
2018-07-03 | Hochstufung | Raymond James | Outperform → Strong Buy |
2018-04-13 | Hochstufung | Goldman | Neutral → Buy |
2018-03-07 | Hochstufung | SunTrust | Hold → Buy |
2018-01-19 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
Iqvia Holdings Inc Aktie (IQV) Neueste Nachrichten
Truist Financial Remains a Buy on IQVIA Holdings (IQV) - The Globe and Mail
IQV stock touches 52-week low at $179.23 amid market challenges - Investing.com India
Here's Why Investors Must Hold IQV Stock in Their Portfolios Now - Yahoo Finance
What Is IQVIA Holdings Inc.'s (NYSE:IQV) Share Price Doing? - Yahoo Finance
Winners And Losers Of Q4: IQVIA (NYSE:IQV) Vs The Rest Of The Drug Development Inputs & Services Stocks - Yahoo Finance
IQVIA Holdings (IQV): Company Profile, Stock Price, News, Rankings - Fortune
Why IQVIA Holdings Inc. (IQV) is Among the Best Diagnostics Stocks to Invest in Right Now - Insider Monkey
Boasting A 23% Return On Equity, Is IQVIA Holdings Inc. (NYSE:IQV) A Top Quality Stock? - Yahoo Finance
Long Term Trading Analysis for (IQV) - Stock Traders Daily
IQVIA Holdings (IQV) Fell on Lowered Guidance - MSN
3 Reasons IQV is Risky and 1 Stock to Buy Instead - Yahoo Finance
IQVIA Holdings Inc.'s (NYSE:IQV) Intrinsic Value Is Potentially 100% Above Its Share Price - Yahoo Finance
Sequoia Financial Advisors LLC Grows Position in IQVIA Holdings Inc. (NYSE:IQV) - MarketBeat
Mizuho Adjusts Price Target on IQVIA Holdings to $242 From $247, Maintains Outperform Rating - Marketscreener.com
Is IQVIA Holdings Stock Underperforming the Dow? - Nasdaq
Jones Financial Companies Lllp Buys 441 Shares of IQVIA Holdings Inc. (NYSE:IQV) - Defense World
Victory Capital Management Inc. Sells 9,038 Shares of IQVIA Holdings Inc. (NYSE:IQV) - Defense World
IQVIA (NYSE:IQV) Downgraded to “Hold” Rating by StockNews.com - Defense World
Argus Adjusts IQVIA Holdings Price Target to $245 From $260, Maintains Buy Rating -March 11, 2025 at 09:47 am EDT - Marketscreener.com
SBI Securities Co. Ltd. Acquires New Holdings in IQVIA Holdings Inc. (NYSE:IQV) - Defense World
(IQV) Investment Report - Stock Traders Daily
IQVIA Holdings Refinances Debt, Lowers Interest Rate By Investing.com - Investing.com South Africa
IQVIA Holdings Refinances Debt, Lowers Interest Rate - Investing.com
IQVIA recognized as a leader in IDC MarketScape’s 2024 assessment for decentralized clinical trial technologies and consulting services - StockTitan
StockNews.com Upgrades IQVIA (NYSE:IQV) to "Buy" - MarketBeat
IQVIA Gains From Diversified Client Base Despite Low Liquidity Woes - Yahoo Finance
M&T Bank Corp Trims Stake in IQVIA Holdings Inc. (NYSE:IQV) - MarketBeat
At US$186, Is It Time To Put IQVIA Holdings Inc. (NYSE:IQV) On Your Watch List? - Simply Wall St
IQVIA at TD Cowen Conference: Strategic Insights and Growth Outlook - Investing.com
Citigroup Issues Pessimistic Forecast for IQVIA (NYSE:IQV) Stock Price - Defense World
IQVIA (NYSE:IQV) Upgraded to Buy at StockNews.com - Defense World
IQVIA (NYSE:IQV) Reaches New 52-Week Low Following Analyst Downgrade - Defense World
Iqvia Laboratories Launches Site Lab Navigator With Breakthrough E-Requisition Innovation To Transform Clinical Trials - Marketscreener.com
Earnings grew faster than the favorable 8.3% CAGR delivered to IQVIA Holdings (NYSE:IQV) shareholders over the last five years - Yahoo Finance
Citigroup Adjusts Price Target on IQVIA Holdings to $210 From $225, Maintains Neutral Rating - Marketscreener.com
How IQVIA's New E-Requisition Technology Could Eliminate Major Clinical Trial Bottlenecks - StockTitan
Zacks Research Issues Optimistic Outlook for IQVIA Earnings - Defense World
Brokers Offer Predictions for IQVIA's Q1 Earnings (NYSE:IQV) - MarketBeat
IQVIA Holdings Inc. (NYSE:IQV) Shares Sold by Y Intercept Hong Kong Ltd - MarketBeat
IQVIA Holdings Inc. (NYSE:IQV) Shares Sold by Tower Bridge Advisors - MarketBeat
Bruni J V & Co. Co. Acquires New Stake in IQVIA Holdings Inc. (NYSE:IQV) - MarketBeat
Proficio Capital Partners LLC Buys Shares of 148,040 IQVIA Holdings Inc. (NYSE:IQV) - MarketBeat
Atria Wealth Solutions Inc. Sells 831 Shares of IQVIA Holdings Inc. (NYSE:IQV) - Defense World
Stack Financial Management Inc Sells 2,198 Shares of IQVIA Holdings Inc. (NYSE:IQV) - MarketBeat
Heritage Investors Management Corp Raises Stock Holdings in IQVIA Holdings Inc. (NYSE:IQV) - MarketBeat
IQVIA Holdings Inc. (NYSE:IQV) Stock Position Lowered by Fjarde AP Fonden Fourth Swedish National Pension Fund - MarketBeat
Pine Valley Investments Ltd Liability Co Boosts Position in IQVIA Holdings Inc. (NYSE:IQV) - MarketBeat
IQVIA Holdings Inc. stock rises Friday, still underperforms market - MarketWatch
IQVIA (NYSE:IQV) Hits New 1-Year LowShould You Sell? - MarketBeat
Zacks Research Issues Optimistic Forecast for IQVIA Earnings - MarketBeat
Versor Investments LP Grows Stock Holdings in IQVIA Holdings Inc. (NYSE:IQV) - MarketBeat
Finanzdaten der Iqvia Holdings Inc-Aktie (IQV)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):